INCREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CONCURRENT HEPATITIS C VIRUS INFECTION AND METABOLIC DYSFUNCTIONASSOCIATED FATTY LIVER DISEASE AFTER ACHIEVING SUSTAINED VIROLOGIC RESPONSE WITH DIRECT- ACTING ANTIVIRALS

被引:0
|
作者
Liu, Chen-Hua [1 ]
Fang, Yu-Jen [2 ]
Chen, Chi-Yi [3 ]
Kao, Wei-Yu [4 ]
Lin, Chih-Lin [5 ]
Cheng, Pin-Nan [6 ]
Yang, Sheng-Shun [7 ]
Shih, Yu-Lueng [8 ]
Huang, Shang-Chin [9 ]
Su, Tung-Hung [1 ]
Tseng, Tai-Chung [1 ]
Liu, Chun-Jen [1 ]
Chen, Pei-Jer [1 ]
Kao, Jia-Horng [1 ]
机构
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Yun Lin Branch, Touliu, Yunlin, Taiwan
[3] Chiayi Christian Hosp, Ditmanson Med Fdn, Chiayi, Taiwan
[4] Taipei Med Univ Hosp, Taipei, Taiwan
[5] Taipei City Hosp, Renai Branch, Taipei, Taiwan
[6] Natl Cheng Kung Univ Hosp, Tainan, Taiwan
[7] Taichung Vet Gen Hosp, Taichung, Taiwan
[8] Triserv Gen Hosp, Taipei, Taiwan
[9] Natl Taiwan Univ Hosp, Bei Hu Branch, Taipei, Taiwan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1839- A
引用
收藏
页码:S695 / S695
页数:1
相关论文
共 50 条
  • [41] Efficacy of hepatitis B virus vaccination in genotype 4 chronic hepatitis C patients achieved sustained virologic response with direct acting antivirals
    Hassany, M.
    Aziz, H. A.
    Rahman, T. A.
    Eysa, B.
    El-Sayed, M. H.
    Samir, A.
    Hassan, M.
    Elshafie, A.
    Asem, N.
    Ibrahem, M.
    Esmat, G.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 182 - 183
  • [42] Predictive Factors for Early Recurrence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Who Achieved Sustained Virologic Response with Direct-Acting Antivirals Therapy
    Miyase, Shiho
    Kugiyama, Aya
    Tsukano, Natsumi
    Iwashita, Hirofumi
    Fujiyama, Shigetoshi
    HEPATOLOGY, 2018, 68 : 856A - 856A
  • [43] Risk factors for liver-related mortality of patients with hepatitis C virus after sustained virologic response to direct-acting antiviral agents
    Hattori, Nobuhiro
    Ikeda, Hiroki
    Watanabe, Tsunamasa
    Satta, Yosuke
    Ehira, Takuya
    Suzuki, Tatsuya
    Kiyokawa, Hirofumi
    Nakahara, Kazunari
    Takahashi, Hideaki
    Matsunaga, Kotaro
    Matsumoto, Nobuyuki
    Yasuda, Hiroshi
    Suzuki, Michihiro
    Itoh, Fumio
    Tateishi, Keisuke
    JGH OPEN, 2022, 6 (10): : 685 - 691
  • [44] Incidence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C and STAGE-3 LIVER Fibrosis after Sustained Virological Response with Direct-Acting Antivirals
    Sanchez Azofra, Maria
    Luisa Montes, Maria
    Fernandez-Rodriguez, Conrado M.
    Moreno, Victoria
    Poza, Joaquin
    Martin-Carbonero, Luz
    Ruiz Fernandez, Gloria
    Valencia, Eulalia
    Jaquotot, Marta
    Ignacio Bernardino, Jose
    Marin, Eva
    Perez-Valero, Ignacio
    De Maria, Pedro
    Gonzalez, Juan
    Tavecchia, Mariana
    Romero, Miriam
    Garcia Sanchez, Araceli
    Carlos Erdozain, Jose
    Gutierrez Garcia, Maria Luisa
    Suarez, Cristina
    Ferrer, Juan
    Mora, Pedro
    Javier Garcia-Samaniego, Francisco
    Olveiral, Antonio
    Castillo, Pilar
    HEPATOLOGY, 2018, 68 : 865A - 866A
  • [45] Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid
    Pham, Timothy T.
    Keast, Shellie L.
    Farmer, Kevin C.
    Thompson, David M.
    Rathbun, Chris
    Nesser, Nancy J.
    Holderread, Bethany P.
    Skrepnek, Grant H.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 664 - 676
  • [46] Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
    D'Ambrosio, Roberta
    Degasperi, Elisabetta
    Lampertico, Pietro
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 713 - 739
  • [47] Sustained Virologic Response of Patients Hospitalized Compared With Those Not Hospitalized During Treatment for Hepatitis C Virus With Direct-Acting Antivirals
    Gentene, Anthony J.
    Bell, Allison M.
    Pence, Alicia
    Thomas, Kelly
    Jakubecz, Collin
    Stacy, Elizabeth
    Woolf, Brittany
    Guido, Maria Rose
    Mueller, Eric W.
    Sherman, Kenneth E.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (05) : 565 - 574
  • [48] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Tajiri, Kazuto
    Ito, Hiroyuki
    Kawai, Kengo
    Kashii, Yoshiro
    Hayashi, Yuka
    Murayama, Aiko
    Minemura, Masami
    Takahara, Terumi
    Shimizu, Yukihiro
    Yasuda, Ichiro
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (06) : 1190 - 1199
  • [49] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Kazuto Tajiri
    Hiroyuki Ito
    Kengo Kawai
    Yoshiro Kashii
    Yuka Hayashi
    Aiko Murayama
    Masami Minemura
    Terumi Takahara
    Yukihiro Shimizu
    Ichiro Yasuda
    World Journal of Hepatology, 2022, 14 (06) : 1190 - 1199
  • [50] Risk of Hepatocellular Carcinoma After Sustained Virological Response in Veterans With Hepatitis C Virus Infection
    El-Serag, Hashem B.
    Kanwal, Fasiha
    Richardson, Peter
    Kramer, Jennifer
    HEPATOLOGY, 2016, 64 (01) : 130 - 137